What the studies show Semaglutide was originally developed and approved as a type 2 diabetes treatment, functioning as a GLP-1 (glucagon-like peptide-1) receptor agonist that stimulates insulin secretion, suppresses glucagon, and lowers blood sugar levels when used alongside diet and exercise
Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D
Nevertheless, vitamin B6s essential role in fat transport and oxidation suggests that a better status may be linked to reduced body-fat accumulation
Comparing Semaglutide to Other Weight Management Options Your weight management decisions become easier when you understand all available options
Epub 2019 Oct 5
Research suggests this may be due to higher concentrations of beta-3 adrenergic receptors in these fat depots